Cyteir Therapeutics Prices IPO Of 7.40 Mln Shares At $18.00/shr

Cyteir Therapeutics Inc. (CYT) said that it has priced its initial public offering of 7.40 million shares of its common stock at price of $18.00 per share.

In addition, Cyteir has granted the underwriters a 30-day option to purchase up to an additional 1.11 million shares of common stock at the initial public offering price, less the underwriting discounts and commissions.

The shares are scheduled to begin trading on The Nasdaq Global Select Market on June 18, 2021 under the ticker symbol "CYT."

The company expects gross proceeds of the offering, before deducting underwriting discounts and commissions and other estimated offering expenses payable by Cyteir, to be about $133 million excluding any exercise of the underwriters' option to purchase additional shares.

The offering is expected to close on June 22, 2021.

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
Sturtevant, Wisconsin-based BRP U.S. Inc. is recalling around 20 models of Side-by-Side vehicles citing fire risk, the U.S. Consumer Product Safety Commission. The recall involves about 34,400 units of Model Years 2020 and 2021 Can-AM Defender HD10 side-by-side vehicles. While reporting financial results for the second quarter on Friday, technology company Honeywell international Inc. (HON) raised its adjusted earnings and sales guidance for the full-year 2021, based on the second-quarter performance and management's outlook for the remainder of the year. For fiscal... Shares of Vodafone Group Plc were gaining around 2 percent in the morning trading in London after the British telecom major reported higher revenues in its first quarter. Looking ahead, the company said it is on track to deliver fiscal year 2022 guidance, with Adjusted EBITDAaL expected to be between 15.0 billion euros - 15.4 billion euros and Adjusted free cash flow of at least 5.2 billion euros
Follow RTT